TLR agonists as vaccine adjuvants: Comparison of CpG ODN and Resiquimod (R-848)

Vaccine

Volumn 23, Issue 45, 2005, Pages 5263-5270

  Weeratna, Risini D ^a   Makinen, Shawn R ^a   McCluskie, Michael J ^a   Davis, Heather L ^a  

^a Coley Pharmaceutical Group ^*  (Canada)

Author keywords

CpG ODN; R 848; TLR ligands; Vaccine adjuvants

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; IMMUNOLOGICAL ADJUVANT; OLIGODEOXYNUCLEOTIDE; RESIQUIMOD; TOLL LIKE RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELLULAR IMMUNITY; COMPARATIVE STUDY; CONTROLLED STUDY; CPG ISLAND; DRUG POTENTIATION; FEMALE; HUMORAL IMMUNITY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODY FORMATION; CYTOKINES; FEMALE; HEPATITIS ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; IMIDAZOLES; IMMUNITY, CELLULAR; IMMUNIZATION; INTERFERON TYPE II; MICE; MICE, INBRED BALB C; OLIGODEOXYRIBONUCLEOTIDES; T-LYMPHOCYTES, CYTOTOXIC; TOLL-LIKE RECEPTORS;

EID: 26644447379     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.06.024     Document Type: Article

References (60)

1. R. Medzhitov, and C.A. Janeway Jr. Innate immunity: the virtues of a nonclonal system of recognition Cell 91 3 1997 295 298
2. S. Akira, K. Takeda, and T. Kaisho Toll-like receptors: critical proteins linking innate and acquired immunity Nat Immunol 2 8 2001 675 680
3. T. Kaisho, and S. Akira Critical roles of Toll-like receptors in host defense Crit Rev Immunol 20 5 2000 393 405
4. T. Kaisho, and S. Akira Toll-like receptors and their signaling mechanism in innate immunity Acta Odontol Scand 59 3 2001 124 130
5. M.A. Morse, J.J. Vredenburgh, and H.K. Lyerly A comparative study of the generation of dendritic cells from mobilized peripheral blood progenitor cells of patients undergoing high-dose chemotherapy J Hematother Stem Cell Res 8 6 1999 577 584
6. H. Tanaka, C.E. Demeure, M. Rubio, G. Delespesse, and M. Sarfati Human monocyte-derived dendritic cells induce naive T cell differentiation into T helper cell type 2 (Th2) or Th1/Th2 effectors. Role of stimulator/responder ratio J Exp Med 192 3 2000 405 412
7. J.L. Viney Dendritic cell subsets: the ultimate T cell differentiation decision makers Gut 45 5 1999 640 641
8. A. Boonstra, C. Asselin-Paturel, M. Gilliet, C. Crain, G. Trinchieri, and Y.J. Liu Flexibility of mouse classical and plasmacytoid-derived dendritic cells in directing T helper type 1 and 2 cell development: dependency on antigen dose and differential toll-like receptor ligation J Exp Med 197 1 2003 101 109
9. A. Mazzoni, and D.M. Segal Controlling the Toll road to dendritic cell polarization J Leukoc Biol 2004
10. T. Chuang, and R.J. Ulevitch Identification of hTLR10: a novel human Toll-like receptor preferentially expressed in immune cells Biochim Biophys Acta 1518 1-2 2001 157 161
11. T.H. Chuang, and R.J. Ulevitch Cloning and characterization of a sub-family of human toll-like receptors: hTLR7, hTLR8 and hTLR9 Eur Cytokine Netw 11 3 2000 372 378
12. F.L. Rock, G. Hardiman, J.C. Timans, R.A. Kastelein, and J.F. Bazan A family of human receptors structurally related to Drosophila Toll Proc Natl Acad Sci USA 95 2 1998 588 593
13. O. Takeuchi, T. Kawai, H. Sanjo, N.G. Copeland, D.J. Gilbert, and N.A. Jenkins TLR6: A novel member of an expanding toll-like receptor family Gene 231 1-2 1999 59 65
14. R. Schwandner, R. Dziarski, H. Wesche, M. Rothe, and C.J. Kirschning Peptidoglycan-and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2 J Biol Chem 274 25 1999 17406 17409
15. A. Yoshimura, E. Lien, R.R. Ingalls, E. Tuomanen, R. Dziarski, and D. Golenbock Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2 J Immunol 163 1 1999 1 5
16. L. Alexopoulou, A.C. Holt, R. Medzhitov, and R.A. Flavell Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3 Nature 413 6857 2001 732 738
17. H. An, Y. Yu, M. Zhang, H. Xu, R. Qi, and X. Yan Involvement of ERK, p38 and NF-kappaB signal transduction in regulation of TLR2, TLR4 and TLR9 gene expression induced by lipopolysaccharide in mouse dendritic cells Immunology 106 1 2002 38 45
18. J.C. Chow, D.W. Young, D.T. Golenbock, W.J. Christ, and F. Gusovsky Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction J Biol Chem 274 16 1999 10689 10692
19. E. Lien, T.K. Means, H. Heine, A. Yoshimura, S. Kusumoto, and K. Fukase Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide J Clin Invest 105 4 2000 497 504
20. S.H. Rhee, and D. Hwang Murine TOLL-like receptor 4 confers lipopolysaccharide responsiveness as determined by activation of NF kappa B and expression of the inducible cyclooxygenase J Biol Chem 275 44 2000 34035 34040
21. A.T. Gewirtz, T.A. Navas, S. Lyons, P.J. Godowski, and J.L. Madara Cutting edge: bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression J Immunol 167 4 2001 1882 1885
22. F. Hayashi, K.D. Smith, A. Ozinsky, T.R. Hawn, E.C. Yi, and D.R. Goodlett The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5 Nature 410 6832 2001 1099 1103
23. F. Heil, H. Hemmi, H. Hochrein, F. Ampenberger, C. Kirschning, and S. Akira Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8 Science 2004
24. H. Hemmi, O. Takeuchi, T. Kawai, T. Kaisho, S. Sato, and H. Sanjo A Toll-like receptor recognizes bacterial DNA Nature 408 6813 2000 740 745
25. F. Takeshita, C.A. Leifer, I. Gursel, K.J. Ishii, S. Takeshita, and M. Gursel Cutting edge: Role of Toll-like receptor 9 in CpG DNA-induced activation of human cells J Immunol 167 7 2001 3555 3558
26. A. Krug, A. Towarowski, S. Britsch, S. Rothenfusser, V. Hornung, and R. Bals Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12 Eur J Immunol 31 10 2001 3026 3037
27. S.J. Gibson, J.M. Lindh, T.R. Riter, R.M. Gleason, L.M. Rogers, and A.E. Fuller Plasmacytoid dendritic cells produce cytokines and mature in response to the TLR7 agonists, imiquimod and resiquimod Cell Immunol 218 1-2 2002 74 86
28. H. Hemmi, T. Kaisho, O. Takeuchi, S. Sato, H. Sanjo, and K. Hoshino Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway Nat Immunol 3 2 2002 196 200
29. A.M. Krieg, A.K. Yi, S. Matson, T.J. Waldschmidt, G.A. Bishop, and R. Teasdale CpG motifs in bacterial DNA trigger direct B-cell activation Nature 374 6522 1995 546 549
30. H. Liang, Y. Nishioka, C.F. Reich, D.S. Pisetsky, and P.E. Lipsky Activation of human B cells by phosphorothioate oligodeoxynucleotides J Clin Invest 98 5 1996 1119 1129
31. A.K. Yi, P. Hornbeck, D.E. Lafrenz, and A.M. Krieg CpG DNA rescue of murine B lymphoma cells from anti-IgM-induced growth arrest and programmed cell death is associated with increased expression of c-myc and bcl-xL J Immunol 157 11 1996 4918 4925
32. A.K. Yi, J.H. Chace, J.S. Cowdery, and A.M. Krieg IFN-gamma promotes IL-6 and IgM secretion in response to CpG motifs in bacterial DNA and oligodeoxynucleotides J Immunol 156 2 1996 558 564
33. T. Jakob, P.S. Walker, A.M. Krieg, E. von Stebut, M.C. Udey, and J.C. Vogel Bacterial DNA and CpG-containing oligodeoxynucleotides activate cutaneous dendritic cells and induce IL-12 production: implications for the augmentation of Th1 responses Int Arch Allergy Immunol 118 2-4 1999 457 461
34. T. Sparwasser, T. Miethke, G. Lipford, A. Erdmann, H. Hacker, and K. Heeg Macrophages sense pathogens via DNA motifs: induction of tumor necrosis factor-a-mediated shock Eur J Immunol 27 7 1997 1671 1679
35. T. Sparwasser, E.S. Koch, R.M. Vabulas, K. Heeg, G.B. Lipford, and J.W. Ellwart Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells Eur J Immunol 28 6 1998 2045 2054
36. K.J. Stacey, M.J. Sweet, and D.A. Hume Macrophages ingest and are activated by bacterial DNA J Immunol 157 5 1996 2116 2122
37. Z.K. Ballas, W.L. Rasmussen, and A.M. Krieg Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA J Immunol 157 5 1996 1840 1845
38. J.S. Cowdery, J.H. Chace, A.K. Yi, and A.M. Krieg Bacterial DNA induces NK cells to produce IFN-gamma in vivo and increases the toxicity of lipopolysaccharides J Immunol 156 12 1996 4570 4575
39. S. Yamamoto, T. Yamamoto, T. Kataoka, E. Kuramoto, O. Yano, and T. Tokunaga Unique palindromic sequences in synthetic oligonucleotides are required to induce IFN [correction of INF] and augment IFN-mediated [correction of INF] natural killer activity J Immunol 148 12 1992 4072 4076
40. J.P. Vasilakos, R.M. Smith, S.J. Gibson, J.M. Lindh, L.K. Pederson, and M.J. Reiter Adjuvant activities of immune response modifier R-848: comparison with CpG ODN Cell Immunol 204 1 2000 64 74
41. M. Bauer, V. Redecke, J.W. Ellwart, B. Scherer, J.P. Kremer, and H. Wagner Bacterial CpG-DNA triggers activation and maturation of human CD11c-, CD123+ dendritic cells J Immunol 166 8 2001 5000 5007
42. H.L. Davis, R. Weeratna, T.J. Waldschmidt, L. Tygrett, J. Schorr, and A.M. Krieg CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen J Immunol 160 2 1998 870 876 [published erratum appears in J Immunol 1999 Mar 1;162(5):3103]
43. A.K. Yi, M. Chang, D.W. Peckham, A.M. Krieg, and R.F. Ashman CpG oligodeoxyribonucleotides rescue mature spleen B cells from spontaneous apoptosis and promote cell cycle entry J Immunol 160 12 1998 5898 5906
44. A.K. Yi, and A.M. Krieg Rapid induction of mitogen-activated protein kinases by immune stimulatory CpG DNA J Immunol 161 9 1998 4493 4497
45. G. Trinchieri Interleukin-12 and its role in the generation of TH1 cells Immunol Today 14 7 1993 335 338
46. P. Scott IL-12: initiation cytokine for cell-mediated immunity Science 260 5107 1993 496 497
47. P. Ahmad-Nejad, H. Hacker, M. Rutz, S. Bauer, R.M. Vabulas, and H. Wagner Bacterial CpG-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartments Eur J Immunol 32 7 2002 1958 1968
48. F. Heil, P. Ahmad-Nejad, H. Hemmi, H. Hochrein, F. Ampenberger, and T. Gellert The Toll-like receptor 7 (TLR7)-specific stimulus loxoribine uncovers a strong relationship within the TLR7, 8 and 9 subfamily Eur J Immunol 33 11 2003 2987 2997
49. R. Schirmbeck, K. Melber, T. Mertens, and J. Reimann Selective stimulation of murine cytotoxic T cell and antibody responses by particulate or monomeric hepatitis B virus surface (S) antigen Eur J Immunol 24 5 1994 1088 1096
50. S. El Mir, and F. Triebel A soluble lymphocyte activation gene-3 molecule used as a vaccine adjuvant elicits greater humoral and cellular immune responses to both particulate and soluble antigens J Immunol 164 11 2000 5583 5589
51. T. Maurer, A. Heit, H. Hochrein, F. Ampenberger, M. O'Keeffe, and S. Bauer CpG-DNA aided cross-presentation of soluble antigens by dendritic cells Eur J Immunol 32 8 2002 2356 2364
52. E. Davila, and E. Celis Repeated administration of cytosine- phosphorothiolated guanine-containing oligonucleotides together with peptide/protein immunization results in enhanced CTL responses with anti-tumor activity J Immunol 165 1 2000 539 547
53. K.J. Stacey, and J.M. Blackwell Immunostimulatory DNA as an adjuvant in vaccination against Leishmania major Infect Immun 67 8 1999 3719 3726
54. J. Wild, M.J. Grusby, R. Schirmbeck, and J. Reimann Priming MHC-I-restricted cytotoxic T lymphocyte responses to exogenous hepatitis B surface antigen is CD4+ T cell dependent J Immunol 163 4 1999 1880 1887
55. S. Zwaveling, S.C. Ferreira Mota, J. Nouta, M. Johnson, G.B. Lipford, and R. Offringa Established human papillomavirus type 16-expressing tumors are effectively eradicated following vaccination with long peptides J Immunol 169 1 2002 350 358
56. X.P. Ioannou, P. Griebel, R. Hecker, L.A. Babiuk, and van Drunen Littel-van den Hurk The immunogenicity and protective efficacy of bovine herpesvirus 1 glycoprotein D plus Emulsigen are increased by formulation with CpG oligodeoxynucleotides J Virol 76 18 2002 9002 9010
57. A.K. Nichani, R.S. Kaushik, A. Mena, Y. Popowych, D. Dent, and H.G. Townsend CpG oligodeoxynucleotide induction of antiviral effector molecules in sheep Cell Immunol 227 1 2004 24 37
58. R.D. Weeratna, M.J. McCluskie, Y. Xu, and H.L. Davis CpG DNA induces stronger immune responses with less toxicity than other adjuvants Vaccine 18 17 2000 1755 1762
59. CpG ODN is safe and highly effective in humans as adjuvant to HBV vaccine: preliminary results of Phase I trial with CpG ODN 7909. The Third Annual Conference on Vaccine Research. 2000; 47 p.
60. Safe and effective use of CpG as adjuvant for HBV vaccination in HIV infection. Proceedings of 10th Conference on Retroviruses and Opportunistic Infection; 2003.